Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate in Women of Childbearing Age – MarketWatch

April 29, 2014 2:15 pm

Leave a Reply

Your email address will not be published. Required fields are marked *


Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now